Classification criteria for Sjögren syndrome have been developed, validated and approved by the American College of Rheumatology and European League Against Rheumatism.
The U.S. Food and Drug Administration (FDA) has granted its breakthrough therapy designation to silver diamine fluoride 38% (Advantage Arrest, Elevate Oral Care) for use in arresting dental caries in children and adults.